Background: Concerns persist about the validity of generalized transfer function-derived, aortic blood-pressure measurements during the administration of vasoactive agents in clinical trials. Hence, we compared this transferfunction method with another, which estimates aortic systolic pressure directly from the late systolic shoulder of the radial pressure wave, after administration of placebo, ramipril, or atenolol.
B
oth the REASON (pREterax in regression of Arterial Stiffness in a contrOlled double-bliNd) Study 1 and the recently published CAFE (Conduit Artery Function Evaluation), a substudy of the AngloScandinavian Cardiac Outcomes Trial, 2 applied radial a tonometry technique and pulse-wave analysis to examine the different effects of conventional and modern therapy on central and upper-limb pressure. These studies found that despite a similar reduction in brachial systolic pressure in all groups, systolic pressure in the aorta and left ventricle was reduced to a greater degree with angiotensinconverting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB), and calcium channel blocker (CCB) compared with ␤-blocking agents. In these studies, the central (aortic and left ventricular) systolic pressure was generated through mathematical transformation process from radial pressure waves.
While this technique was approved by the US Food and Drug Administration, and supported by previous validation studies, [3] [4] [5] the application of generalized transfer function may be challenged, because it assumes that the aortic-radial transfer function is constant under different circumstances, including the use of vasoactive drugs. Hence, we compared central systolic pressure, derived from generalized transfer function, with another method that estimates aortic systolic pressure from the late systolic shoulder of the radial pressure wave, also using radial applanation tonometry. 6 -8 In determining values of aortic systolic pressure, we were assured by the conclusions of Smulyan et al 9 that the main source of measurement error in the SphygmoCor system (AtCor Medical, Sydney, Australia) is the variability and inaccuracy of cuff pressure used in the calibration of radial artery pressure.
Methods
Data were collected from a group of 30 subjects (25 men and 5 women; mean age, 67 years; SD, 10 years) with Ն1 coronary risk factor (hypertension, diabetes mellitus, hypercholesterolemia, or smoking). Of these subjects, 10 had myocardial ischemia, and 18 had angiography-proven angina. Details of this study were previously described. 10 Briefly, the study was performed according to an acute, randomized, placebocontrolled, double-blind crossover method. Subjects' regular vasoactive medications were withdrawn for at least five half-lives before the session, and they received either 10 mg of ramipril, 100 mg of atenolol, or placebo. Measurements were made at baseline, and at 30, 60, 120, 180, 240, and 300 min after baseline. The study protocol was approved by the Research Ethics Committee of St. Vincent's Hospital, and all subjects gave written, informed consent.
After 15 min of rest in a quiet, temperature-controlled room, brachial blood pressure was taken in the supine position with a standard adult-size cuff mercury sphygmomanometer, using the Korotkov technique, and Phase 5 was taken as the diastolic pressure. As in the REASON and CAFE Trials, radial pressure pulse waveforms were recorded using the SphygmoCor system, [3] [4] [5] calibrated by cuff systolic and diastolic pressure obtained from the brachial artery. For each series of radial pressure waves, the corresponding aortic pressure pulse waveform was generated, using the generalized transfer function.
We focused on the effects of ramipril and atenolol during steady state (measurements taken 180, 240, and 300 min after oral administration). The pressure pulse waveforms from directly recorded radial and derived aortic were ensemble-averaged between 180 to 300 min from drug administration. Central systolic pressure was determined by two methods: (1) the peak of the aortic derived pressure waveform, and (2) the late systolic shoulder of the directly measured radial pressure waveform (inflection technique). Student's t-test was employed to examine the difference between central systolic pressures calculated by Methods 1 and 2, with P Ͻ .05 considered statistically significant.
Results
During the steady-state period (180 to 300 min after active therapy), the reduction in central systolic pressure estimated by Method 2 was 15.8 mm Hg (SD, 12.2 mm Hg) greater with ramipril than with atenolol (Fig. 1) . This value was similar to the reduction in central systolic pressure calculated by Method 1 (14.6 mm Hg; SD, 11.2 mm Hg). No significant difference was found between those values. The reduction in systolic pressure determined by both methods was calculated from the average of all individual responses in systolic pressure with each active therapy.
As we reported previously, 10 ramipril caused a greater reduction in brachial systolic pressure (from 140.8 mm Hg at baseline to 128.9 mm Hg at steady state) compared with atenolol (141.4 mm Hg at baseline to 138.9 mm Hg at steady state) ( Table 1 ). This reduction was even greater in aortic systolic pressure with ramipril (from 130.9 mm Hg at baseline to 117.1 mm Hg at steady state), whereas aortic systolic pressure did not change with atenolol (131.2 to 132.0 mm Hg) (Table 1). There was no significant difference between baseline pressure and measured pressure during steady state between ramipril, atenolol, and placebo (Table 1 ). Significant differences were found between the change in systolic pressure (or net response) measured in both brachial and aortic, due to ramipril, atenolol, and placebo.
The mean difference between central systolic pressures measured from radial (Method 2) and aortic (Method 1), described by the Bland-Altmann method, was 1.6 mm Hg (SD, 8.9 mm Hg) (Fig. 2) . However, the estimation of central systolic pressure from radial pressure wave (Method 2) appeared less reliable. We were unable to estimate central systolic pressure using Method 2 in one subject: the late systolic shoulder could not be identified, whereas the peak of all aortic pressure waves, used in Method 1 to calculate central systolic pressure, could be readily determined.
Our previous study reported that the reduction of aortic systolic pressure with ramipril over atenolol was 5 to 6 mm Hg greater than recorded in the upper limb. 10 The fall of late systolic shoulder in radial pressure wave calculated, as the reduction of aortic systolic pressure (Method 2), was even greater-i.e. 1 to 2 mm Hg more than estimated with the first method (Fig. 3) .
To confirm our finding that the two methods were equivalent in practice, we also analyzed a patient database that consisted of recordings from 1505 patients attending an outpatient cardiology department. The majority of these adult patients suffered from ischemic heart disease, hypertension, or cardiac failure, and thus were similar to the groups studied in the previous trials. The mean difference in systolic pressure measured by Methods 1 and 2 was 1.3 mm Hg (SD, 5.0 mm Hg) (Fig. 4) .
Discussion
The important message of the REASON and CAFE Trials is that the benefits of ACEIs and CCBs over ␤-blocker therapy for hypertension are attributable to a greater reduction in central rather than brachial systolic pressure. There was some unease about this interpretation, because the SphygmoCor method for calculating aortic pressure employed the same generalized transfer function process under all circumstances, and it was assumed that the drugs utilized did not alter the transfer function. There is strong evidence to support such a view. 3, 4, [11] [12] [13] [14] [15] The upper-limb transfer function shows little change with doses of nitroglycerine that cause profound changes in the contour of arterial waves. Such changes as are seen (eg, reduction in peak amplitude of the modulus) with a vasodilator agent would show less, rather than more, effect with a vasodilator such as ramipril on aortic systolic pressure. Modeling studies 16, 17 showed that relatively large changes in upperlimb vascular properties have little effect on the transfer function and even less on the compound wave generated in the aorta. Further, in the REASON Study, 1 carotid pressure waves were recorded together with radial waveforms, and virtually identical results were seen when these carotid waves were used to describe the differential effect of an ACEI-and-diuretic combination versus atenolol. Similar beneficial effects on carotid systolic pressure were seen with a vasodilating ␤-blocker compared with atenolol. 18 In the present study, when no transfer process was used, the reduction in central pressure with ramipril compared with atenolol was similar when the direct radial contour technique was used instead of the SphygmoCor process.
These data provide further support for the view that such "new" arterial vasodilating antihypertensive agents as ramipril, losartan, amlodipine, and perindopril are superior to atenolol because of their ability to reduce central carotid and aortic pressure to a greater degree than bra-
FIG. 2.
Bland-Altman plot of differences in individual data points of late radial systolic shoulder as representation of central systolic pressure (Method 2) and of aortic pressure peak as systolic pressure (Method 1). Data were collected from 30 patients during steady-state period (180, 240, and 300 min after drug administration). In total, 87 points were obtained, because the system was unable to identify any late systolic radial shoulder in one subject. There was no significant difference between measures taken at the two sites. Dashed lines indicate Ϯ 2SD.
FIG. 3. Left:
As a consequence of the differential effects of ramipril and atenolol on central and peripheral systolic pressure, the difference in the effect on aortic compared with upper-limb systolic pressure was underestimated by 5.2 mm Hg between 3 to 5 h after dosing. 10 The difference in the effect on aortic in comparison with late systolic shoulder in radial pressure was similar (7.2 mm Hg) during this period. Error bars indicate Ϯ1 SD. Right: The difference between values of systolic pressure fall by the two methods described on bottom left panel, with error bars indicating Ϯ1 SEM. SEM ϭ Standard error of measurements.
chial pressure. A recent study comparing an ACEI (enalapril) versus a diuretic (indapamide) as monotherapy showed the superiority of the ACEI over the diuretic in the reduction of central aortic pressure without change in heart rate. 19 
